Galapagos NV (NASDAQ:GLPG)
| 54.21 Delayed Data As of 4:14pm ET |  +0.68 / +1.27%Today’s Change | 53.30 Today|||52-Week Range 148.68 | -45.23% Year-to-Date |
Latest GLPG News | Press Releases
No recent news for Galapagos NV.
Today’s Trading
| Previous close | 53.53 |
| Today’s open | 54.33 |
| Day’s range | 54.16 - 54.81 |
| Volume | 4,833 |
| Average volume (3 months) | 289,579 |
| Market cap | $3.5B |
Data as of 4:14pm ET, 09/27/2021
Growth & Valuation
| Earnings growth (last year) | -283.81% |
| Earnings growth (this year) | +27.97% |
| Earnings growth (next 5 years) | -13.09% |
| Revenue growth (last year) | -42.38% |
| P/E ratio | NM |
| Price/Sales | 11.82 |
| Price/Book | 1.07 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| KRTXKaruna Therapeutics ... | +3.79 | +3.19% |
| ARNAArena Pharmaceutical... | +1.13 | +1.88% |
| TPTXTurning Point Therap... | -1.58 | -2.12% |
| ---- |
Data as of 4:14pm ET, 09/27/2021
Financials
| Next reporting date | November 4, 2021 |
| EPS forecast (this quarter) | -$1.57 |
| Annual revenue (last year) | $545.0M |
| Annual profit (last year) | -$348.2M |
| Net profit margin | -65.06% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Mechelen, Brussels Region |
Forecasts
